Correlation Between Bank of America and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bank of America and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Bank of America and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Recursion Pharmaceuticals.
Diversification Opportunities for Bank of America and Recursion Pharmaceuticals
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Bank and Recursion is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Bank of America i.e., Bank of America and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bank of America and Recursion Pharmaceuticals
Considering the 90-day investment horizon Bank of America is expected to generate 0.2 times more return on investment than Recursion Pharmaceuticals. However, Bank of America is 4.88 times less risky than Recursion Pharmaceuticals. It trades about 0.28 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest 3,955 in Bank of America on April 26, 2025 and sell it today you would earn a total of 884.00 from holding Bank of America or generate 22.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Bank of America vs. Recursion Pharmaceuticals
Performance |
Timeline |
Bank of America |
Recursion Pharmaceuticals |
Bank of America and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bank of America and Recursion Pharmaceuticals
The main advantage of trading using opposite Bank of America and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.Bank of America vs. JPMorgan Chase Co | Bank of America vs. Nu Holdings | Bank of America vs. Goldman Sachs Group | Bank of America vs. Pfizer Inc |
Recursion Pharmaceuticals vs. Zura Bio Limited | Recursion Pharmaceuticals vs. Elevation Oncology | Recursion Pharmaceuticals vs. Verve Therapeutics | Recursion Pharmaceuticals vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |